Israel’s BioProtect (see here previously) has received US FDA’s clearance for its biodegradable balloon spacer that protects healthy tissue against damage during prostate cancer radiation therapy.  BioProtect already has approval for the European market. https://bioprotect.com/ https://www.youtube.com/watch?v=E-n3ojSivVY https://www.prnewswire.com/il/news-releases/bioprotect-receives-fdas-clearance-for-its-biodegradable-balloon-for-rectal-protection-during-prostate-cancer-radiation-therapy-301911041.html

Researchers at Israel’s Ariel University have enhanced the ability of Photodynamic cancer therapy (PDT) to reach tumors deep inside the body. They used nanoparticles of barium titanate, curcumin (turmeric) and pulsed lasers to optimize the Near Infrared Light. https://www.jpost.com/health-and-wellness/article-754826# https://www.sciencedirect.com/science/article/pii/S1386142523008806

Israel’s MediWound (see here previously) announced positive data from its Phase I/II study of MW005 for non-surgical treatment of Basal Cell Carcinoma (BCC) – a form of slow-growing skin cancer.  MW005 is safe, well-tolerated and completely cleared the BCC lesions. … Continue reading →

Researchers at Tel Aviv University (TAU) have developed a computational model that makes it possible to predict an individual woman’s genetic risk of developing breast cancer based on her genetic profile. It means women at risk can be tested earlier … Continue reading →

Israel’s Nevia Bio (previously Gina Life) specializes in women’s health, using its innovative machine-learning platform to detect diseases while they are still curable. Nevia is initially targeting ovarian cancer, which has a less than 20% survival rate at stage 3 … Continue reading →